Advertisement

Comparative Trial of N-Acetyl-Cysteine, Taurine, and Oxerutin on Skin and Kidney Damage in Long-Term Experimental Diabetes

  1. Patrizio Odetti1,
  2. Carlo Pesce2,
  3. Nicola Traverso3,
  4. Stefano Menini2,
  5. Elena Pesce Maineri3,
  6. Luana Cosso3,
  7. Sabina Valentini1,
  8. Stefania Patriarca3,
  9. Damiano Cottalasso3,
  10. Umberto M. Marinari3 and
  11. Maria Adelaide Pronzato3
  1. 1Department of Internal Medicine, University of Genova, Genova, Italy
  2. 2Centre of Pathological Anatomy (CLOPD) DISTBIMO, University of Genova, Genova, Italy
  3. 3Department of Experimental Medicine, University of Genova, Genova, Italy

    Abstract

    This study analyzes the effect of chronic treatment with different antioxidants (N-acetyl-cysteine [NAC], taurine, a combination of NAC and taurine, and oxerutin) on long-term experimental diabetes induced by streptozotocin in rats. Glycoxidative damage was evaluated in the skin; glomerular structural changes were studied with morphometry and immunohistochemistry. Oxerutin treatment and the combined NAC plus taurine treatment resulted in reduced accumulation of collagen-linked fluorescence in skin in comparison with untreated diabetic rats. All treatments except taurine reduced glomerular accumulation of Nε-(carboxymethyl)lysine and protected against the increase in glomerular volume typical of diabetes; furthermore, the apoptosis rate was significantly decreased and the glomerular cell density was better preserved. Glycoxidative markers in the skin turned out to be good indicators of the glomerular condition. The findings that emerged from our study support the hypothesis that glomerular damage in diabetes can be prevented or at least attenuated by supplementation with specific antioxidants. Treatment with oxerutin and combined treatment with NAC plus taurine gave the most encouraging results, whereas the results of taurine-only treatment were either negligible or negative and therefore suggest caution in the use of this molecule in single-drug treatment courses.

    Footnotes

    • Address correspondence and reprint requests to Nicola Traverso, DIMES, Section of General Pathology, Via LB Alberti 2, 16151 Genova, Italy. E-mail ntravers{at}medicina.unige.it.

      Received for publication 27 June 2002 and accepted in revised form 22 October 2002.

      AGE, advanced glycation end product; CML, Nε-(carboxymethyl)lysine; HNE, 4-hydroxynonenal; HPLC, high-performance liquid chromatography; MDA, malondialdehyde; MGV, mean glomerular volume; NAC, N-acetyl-cysteine; OXE, oxerutin; ROS, reactive oxygen species; TAU, taurine; TGF, transforming growth factor; TUNEL, transferase-mediated dUTP nick-end labeling.

    | Table of Contents
    Advertisement